AzTrials
AzTrials

Pre Operative SedationNCT02134327

Effect of Dexmedetomidine Versus Midazolam Versus a Combination of the Two as a Premedication for Children Undergoing Bilateral Myringotomy Tube Insertion

A study testing Combination of Dexmedetomidine with Midazolam in people with Pre Operative Sedation and Mask Acceptance, run by Nemours Children's Clinic at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Following an obtained written consent, a child presenting for ear tube surgery will be randomized into one of three groups for receiving a premedication. One group will be the current therapy with midazolam, another group will be another drug dexmedetomidine, and the third group will be a combination of midazolam plus… Read more about this study

Who is it for?
Ages 6 months to 4 yearsHealthy volunteers can take part
What is being tested?
Combination of Dexmedetomidine with Midazolam
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
Apr 2014to Apr 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 months to 4 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Age 6 mo-4 years
  • ASA classification 1 or 2
  • Vital signs, namely heart rate and blood pressure within the normal range for each patient's age group

Who cannot join

  • Known allergies to midazolam or dexmedetomidine
  • Baseline vitals outside the range listed above
  • Personal or family history of malignant hyperthermia
  • Genetic abnormalities predisposing to altered hemodynamics or difficult airway
  • ASA physical status 3 or greater
  • Known cardiac abnormalities

Trial locations and contacts

1 site in 1 country.

United States1 site
  • A.I. Dupont Hospital for Children

    Wilmington, Delaware, 19803

Other trials in United States

About this study

Official title: Effect of Dexmedetomidine Versus Midazolam Versus a Combination of the Two as a Premedication for Children Undergoing Bilateral Myringotomy Tube Insertion: A Randomized, Blinded Study

Following an obtained written consent, a child presenting for ear tube surgery will be randomized into one of three groups for receiving a premedication. One group will be the current therapy with midazolam, another group will be another drug dexmedetomidine, and the third group will be a combination of midazolam plus dexmedetomidine. Observers in the study (the investigators fellow and advance practice nurse) will not know which group each patient belongs, and will then make three separate assessments: preoperative sedation, mask acceptance, and postoperative delirium.

Mask acceptance: Induction of anesthesia, or the beginning of the process for the patient to fall asleep and lose consciousness, involves placing a mask over there face, specifically the nose and mouth. The mask is connected to their anesthesia machine via tubing, or a circuit, through which their anesthetic gases flow. Some children fight the mask as it can be seen as new and frightening. Other children, sometimes depending on how sedated they are after receiving a premedication, do not fear the mask on their face and do not resist induction. How well or easily this happens can be described as "mask acceptance." Postoperative delirium can be seen in patients of any age or after any surgery and can be better defined as a mental disturbance during the recovery from general anesthesia consisting of hallucinations, delusions, and confusion manifested by moaning, restlessness, involuntary physical activity, and thrashing about in bed. It has been considered a common postanesthetic problem in children and adults since 1960.

Each patient will then have a set of numbers for each scale; following conclusion of the study the investigators will be able see which drug each patient received and statistical analysis can be completed. The investigators goal is to see if there is any difference in any of the scales depending which medication was administered. The scales to be utilized include the pre-operative sedation scale, the mask acceptance scale, and the pediatric emergence delirium scale.

Read the detailed description

Children presenting for ear tube surgery (bilateral myringotomy and ventilating tube insertion) often suffer from postoperative delirium in the recovery room. It has been hypothesized this may be a result or side effect of a premedication, midazolam. Midazolam is frequently administered to children preoperatively as a means of decreasing separation anxiety. An alternative medication, dexmedetomidine, is sometimes used as an alternative to midazolam and has also been effective in treating postoperative delirium. In this study the investigators would like to see if there is in fact a measurable difference between children receiving the standard midazolam or dexmedetomidine.

Patients would be randomized into one of three groups (versed alone, dexmedetomidine alone, or a combination). Patients included would be those presenting for BMT surgery who are an ASA physical status 1 or 2, not falling into any exclusion criteria.

Exclusion criteria would be patients with vital signs outside the normal limits as documented under the research plan. Also to be excluded are those patients with known genetic abnormalities predisposing to a derangement in hemodynamics or challenging airway.

The anesthesiologists listed as team members are the ones who are involved with this study and would be responsible for providing a standard anesthetic (same technique with inhalational anesthetic agents and intraoperative pain management) so no other variability would need to be taken into consideration for assessment in the recovery room. The investigators researchers, both anesthesiologists and observers will be blinded during the study. The pharmacy will have a list of patients who have consented, and then will randomly allocate them into one of the three groups. Only for analysis will the investigators (myself as the PI and other members) know which patient received which drug or combination. Also, by having the same team members performing assessment of each of the three parameters (1. Pre-op sedation scale, 2. Mask acceptance score, and 3. Post operative emergence delirium scale), there would be good reliability. A briefing session will be performed prior to the study's commencement showing pictures to the reviewers so there can be an agreed upon assessment. The MOASS or pre-operative sedation scale as well as the mask acceptance and PAED scale have been utilized and validated in previous studies (10), while the mask acceptance scale has been successfully utilized as well (11, 12, 13). The investigators goal is to decrease variability by having only two members make observations.

DESCRIPTION IN LAYMEN TERMS. Please summarize this study in less than 10 sentences. Use language an informed non-scientist can understand. Please complete within space below.

Following an obtained written consent, a child presenting for ear tube surgery will be randomized into one of three groups for receiving a premedication. One group will be the current therapy with midazolam, another group will be another drug dexmedetomidine, and the third group will be a combination of midazolam plus dexmedetomidine. Observers in the study (the investigators fellow and advance practice nurse) will not know which group each patient belongs, and will then make three separate assessments: preoperative sedation, mask acceptance, and postoperative delirium.

Mask acceptance: Induction of anesthesia, or the beginning of the process for the patient to fall asleep and lose consciousness, involves placing a mask over there face, specifically the nose and mouth. The mask is connected to their anesthesia machine via tubing, or a circuit, through which their anesthetic gases flow. Some children fight the mask as it can be seen as new and frightening. Other children, sometimes depending on how sedated they are after receiving a premedication, do not fear the mask on their face and do not resist induction. How well or easily this happens can be described as "mask acceptance." Postoperative delirium can be seen in patients of any age or after any surgery and can be better defined as a mental disturbance during the recovery from general anesthesia consisting of hallucinations, delusions, and confusion manifested by moaning, restlessness, involuntary physical activity, and thrashing about in bed. It has been considered a common postanesthetic problem in children and adults since 1960.

Each patient will then have a set of numbers for each scale; following conclusion of the study the investigators will be able see which drug each patient received and statistical analysis can be completed. The investigators goal is to see if there is any difference in any of the scales depending which medication was administered. The scales to be utilized include the pre-operative sedation scale, the mask acceptance scale, and the pediatric emergence delirium scale.

Being tested
Combination of Dexmedetomidine with Midazolam

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Combination of Dexmedetomidine with MidazolamDrug

Study groups in NCT02134327
Study groupRoleWhat they receive
Premedication with MidazolamExperimentalNot described
Receives: Drug: Combination of Dexmedetomidine with Midazolam

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post operative anesthesia emergence delerium scale

    The primary outcome will be which group of subjects have different PAED or emergence derlium scale scores.

    Measured: From beginning of when patient receives medication for assessing preoperative sedation to recovery room when postoperative delerium is assessed. This whole process takes approximately 90 minutes.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 May 2014 (estimated)
  2. Study startApr 2014
  3. Primary completionApr 2014 (estimated)
  4. Study completionApr 2014

Why it stopped: Decided not to proceed

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02134327
Sponsor's protocol ID
JB004-1
Status last verified
May 2023
First submitted
1 May 2014
Last updated
23 May 2023
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Combination of Dexmedetomidine with Midazolam in people with Pre Operative Sedation and Mask Acceptance, run by Nemours Children's Clinic at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 23 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post operative anesthesia emergence delerium scale (time frame: From beginning of when patient receives medication for assessing preoperative sedation to recovery room when postoperative delerium is assessed. This whole process takes approximately 90 minutes.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2023; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in